U.S. Department of Health and Human Services
Aaron Pawlyk

 Contact Info

Tel: +1 301 451 7299
Email: pawlykac@mail.nih.gov

 Select Experience


Adjunct Assistant Professor, Department of Pharmacology and Physiology, Drexel University College of Medicine, 2010-2013

Adjunct Professor of Pharmacology, Pennsylvania Drug Discovery Institute, 2010-2011

Director of Pharmacology, ALS Biopharma, 2009-2011

Ph.D., Texas A&M University, 2001

Aaron Pawlyk, Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities and Activitites

I am director of the Diabetes and Endocrine Disease Translational Research program.  This portfolio supports a variety of research relevant to the development of therapies for diabetes, endocrine, and metabolic disorders.  This includes research on physiological and pathophysiological processes, molecular structures or biological pathways, and the bioavailability of compounds.  Studies in this portfolio examine the ability to selectively modulate the function of drug discovery targets and the ability to translate biological endpoints of preclinical research to the clinic.

The Diabetes Genetics and Genomics program supports research on the genetic and epigenetic variations that influence the effectiveness and safety of pharmacotherapy for diabetes and other disorders of interest.  The portfolio promotes efforts to build a strong evidence base for personalized medicine and to translate these and other findings into clinical practice.

My other professional activities include participating in several NIDDK working groups—including ones that focus on type 2 diabetes, obesity, and clinical studies, as well as leading the trans-NIDDK Translational Sciences Working Group.

​Research Programs

Diabetes and Endocrine Disease Translational Research
The Diabetes and Endocrine Disease Translational Research program promotes research that translates scientific findings into practice to enhance human health of those with, or at risk for, metabolic disease, including diabetes and endocrine diseases

Diabetes Genetics and Genomics
This program advances research to identify the genetic mechanisms underlying type 1 and type 2 diabetes—and how genetic and epigenetic variation influences the metabolism of therapeutics—with an aim towards developing better treatments

Metabolic Pathways
This program supports research on the pathways that are involved in intermediary metabolism, from a whole-body, tissue, cellular, or the molecular perspective, as they impact metabolic diseases

Committee Membership

NIH Common Fund Illuminating the Druggable Genome Working Group, Member

​NIDDK Type 2 Diabetes Working Group, Member

NIH Gerosciences Interest Group, Member

NIDDK Obesity Working Group, Member

Molecular Libraries Screening Centers, DEM, NIDDK, NIH, Science Officer​

NIDDK Translational Sciences Working Group, Chair